Center for Clinical and Translational Sciences (CCTS)
Center for Clinical and Translational Sciences (CCTS)
批准号:
10707570
负责人:
DANIEL D KARP
金额:
$7.15万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-24 至 2024-06-30
关键词:
AccelerationAddressAmericanAreaAwardBasic ScienceBiomedical ResearchCancer CenterChildhoodChronic lung diseaseClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCollaborationsCommunitiesCommunity HealthConduct Clinical TrialsCountryDataDoctor of MedicineEducationElderlyEnvironmentFirst Independent Research Support and Transition AwardsFosteringGoalsHealthHealth SciencesHealthcareHispanicHospitalsIndividualInformaticsInstitute of Medicine (U.S.)InstitutionInstitutional Review BoardsKnowledgeLearningLesbian Gay Bisexual Transgender QueerMalignant NeoplasmsMedicalMedical FacultyMedical StaffMedical centerMedicineMethodist ChurchMethodsMexican AmericansMulti-Institutional Clinical TrialNational Center for Advancing Translational SciencesPatientsPhysiciansPopulationPopulation HeterogeneityProcessReportingResearchResearch ContractsResearch PersonnelResourcesRiceRuralRural HealthSchoolsScienceServicesSiteSolidSouth TexasTexasTrainingTranslational ResearchTranslationsTuberculosisUniversitiesWorkWorkforce Developmentbasebench to bedsidebiobankcancer carecancer clinical trialclinical careclinical centerclinical data warehousecollegecommunity engagementcomputer scienceeconomic disparityhealth trainingimprovedinnovationinter-institutionalmultidisciplinarynext generationnoveloutreachpatient registrypopulation basedprogramsskillstranslational pipelinetranslational scientist
中文摘要
联系 PD/PI:McPherson、David D.
在首届 CTSA 类别中,临床和转化科学中心 (CCTS) 组建了第一个
多机构 CTSA,包括德克萨斯大学休斯顿健康科学中心 (UTHSC-H) 和
德克萨斯大学 MD 安德森癌症中心 (UT MDACC)。自CCTS成立以来,
实现临床和转化科学奖 (CTSA) 计划的主要目标:加速
研究旨在改变医疗保健并培训下一代转化科学家。我们最初的建议
旨在将个人和资源聚集在一起,教育调查人员并建立团队。在我们的
2011 年更新中,我们描述了“降低障碍”计划,该计划的重点是消除大量
通过IRB互惠、标准研究合同和分包合同、临床研究等举措来消除障碍
数据仓库、患者登记处和生物库。我们的努力是成功的,并且与
国家 CTSA 计划。在此周期中,我们引入了 3 个新的合作伙伴机构,以扩大我们的业务范围并使其多元化
CTSA:位于泰勒的德克萨斯大学健康科学中心(德克萨斯州东北部,农村,经济
弱势)、莱斯大学(在计算机科学、教育和团队科学方面具有优势)、
和德克萨斯大学里奥格兰德河谷分校(德克萨斯州南部)的教育和医师资源
帮助我们附近的布朗斯维尔临床研究单位进行临床试验)。我们将一起实现 5
战略目标: 战略目标 1:为我们的研究人员、工作人员、受训人员和学者提供
在新环境中推进发现及其转化所需的技能和知识
临床和转化研究(劳动力发展)。战略目标2:与所有人合作
我们的利益相关者以互惠互利的方式通过进一步参与和推进翻译
团队科学(协作/参与)。战略目标 3:整合儿科和老年科
患者、西班牙裔癌症患者和 LGBTQ 群体进入全方位的临床治疗
和转化研究(整合)。战略目标 4:通过以下方式推进转化科学:
提供新颖的流程、提高效率并简化研究(方法/流程)。
战略目标 5. 创建并应用创新信息学解决方案以推进转化
研究、培训 CTSA 员工、传播最佳实践、吸引社区并整合
临床和基础研究数据(信息学)。
第373页
项目概要/摘要
联系 PD/PI:McPherson、David D.
CCTS 将支持双向转化研究,将发现从实验室转移到临床,
通过利用我们独特的多学科翻译团队和创新技术培训一支有能力的员工队伍
教育计划。我们的中心将致力于促进高质量的临床研究,开发最佳实践
基于团队的翻译,参与机构间数据共享,并作为多方翻译的高效站点
在我们庞大且多样化的人群中进行临床试验。 CCTS 通过其新颖的计划和资源,将
仍然是实现国家联盟目标的重要贡献者。
第374页
英文摘要
Contact PD/PI: McPherson, David D.
In the first awarded CTSA class, the Center for Clinical and Translational Sciences (CCTS) formed the first
multiple-institution CTSA, with The University of Texas Health Science Center at Houston (UTHSC-H) and The
University of Texas M. D. Anderson Cancer Center (UT MDACC). Since its inception the CCTS has been
achieving the primary goal of the Clinical and Translational Sciences Award (CTSA) program: to accelerate
research to transform healthcare and train the next generation of translational scientists. Our initial proposal
was about bringing individuals and resources together, educating investigators, and building teams. In our
2011 renewal we described our Lowering-The-Barriers program, which focused on removing a large number of
impediments through initiatives such as IRB reciprocity, standard research contracts and subcontracts, clinical
data warehouses, patient registries, and biobanks. Our efforts have been successful and aligned with the
national CTSA program. In this cycle, we bring in 3 new partner institutions to broaden and diversify our
CTSA: The University of Texas Health Science Center at Tyler (northeast Texas, rural, economically
disadvantaged), Rice University (with strengths in computer science, education, and team science),
and The University of Texas Rio Grande Valley (south Texas, education and physician resources to
help our nearby Brownsville Clinical Research Unit perform clinical trials). Together we will effect 5
strategic goals: Strategic Goal 1: To provide our investigators, staff, trainees, and scholars with the
skills and knowledge necessary to advance discoveries and their translation in the new environment of
clinical and translational research (Workforce Development). Strategic Goal 2: To collaborate with all
of our stakeholders in a mutually beneficial way to advance translation by furthering engagement and
team science (Collaboration/Engagement). Strategic Goal 3: To integrate pediatric and geriatric
patients, Hispanic patients with cancer, and the LGBTQ+ community into the full spectrum of clinical
and translational research (Integration). Strategic Goal 4: To advance translational science by
providing novel processes, increasing efficiency, and streamlining research (Methods/Processes).
Strategic Goal 5. To create and apply innovative informatics solutions to advance translational
research, train the CTSA workforce, disseminate best practices, engage communities and integrate
clinical and basic research data (Informatics).
Page 373
Project Summary/Abstract
Contact PD/PI: McPherson, David D.
The CCTS will support bidirectional translational research, moving discoveries from the bench to the bedside,
by training a capable workforce using our unique multidisciplinary translational teams and innovative
educational programs. Our hub will serve to foster high-quality clinical research, develop best practices in
team-based translations, participate in inter-institutional data-sharing, and function as an efficient site for multi-
site clinical trials in our large, diverse populations. The CCTS, through its novel programs and resources, will
remain an important contributor to achieving the goals of the national consortium.
Page 374
期刊论文(308)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1096/fj.202002407r
发表时间:
2021-04
期刊:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
影响因子:
--
作者:
[Berg NK, Li J, Kim B, Mills T, Pei G, Zhao Z, Li X, Zhang X, Ruan W, Eltzschig HK, Yuan X]
通讯作者:
Yuan X
DOI:
10.21037/tp-20-315
发表时间:
2021-08
期刊:
Translational pediatrics
影响因子:
2
作者:
[Findley TO, Northrup H]
通讯作者:
Northrup H
DOI:
10.1007/s10637-021-01119-0
发表时间:
2021-10
期刊:
Investigational new drugs
影响因子:
3.4
作者:
[Thein KZ, Piha-Paul SA, Tsimberidou A, Karp DD, Janku F, Zarifa A, Shah J, Milton DR, Bean S, McQuinn L, Gong J, Colen R, Carter BW, Subbiah V, Ogbonna DC, Pant S, Meric-Bernstam F, Naing A]
通讯作者:
Naing A
DOI:
10.4103/bc.bc_44_21
发表时间:
2021-10
期刊:
Brain circulation
影响因子:
1.9
作者:
[Inam ME, Sanzgiri A, Lekka E, Sheth SA, Barreto AD, Savitz SI, Artime C, Pedroza C, Engstrom A, Sheriff FG, Ambrocik A, Chen PR]
通讯作者:
Chen PR
DOI:
10.1038/s41698-021-00159-2
发表时间:
2021-03-19
期刊:
NPJ precision oncology
影响因子:
7.9
作者:
[Tsimberidou AM, Hong DS, Fu S, Karp DD, Piha-Paul S, Kies MS, Ravi V, Subbiah V, Patel SM, Tu SM, Janku F, Heymach J, Johnson A, Cartwright C, Zhao L, Zhang J, Berry DA, Vining DJ, Futreal A, Miller VA, Meric-Bernstam F]
通讯作者:
Meric-Bernstam F
共 184 条
Center for Clinical and Translational Sciences (CCTS)
-
批准号:10316843
-
项目类别:
-
资助金额:$185.96万
-
财政年份:2021
-
负责人:DANIEL D KARP
-
依托单位:
Center for Clinical and Translational Sciences (CCTS)
-
批准号:10295669
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2021
-
负责人:DANIEL D KARP
-
依托单位:
Center for Clinical and Translational Sciences (CCTS)
-
批准号:10217650
-
项目类别:
-
资助金额:$40.62万
-
财政年份:2020
-
负责人:DANIEL D KARP
-
依托单位:
Center for Clinical and Translational Sciences (CCTS)
-
批准号:10654064
-
项目类别:
-
资助金额:$290.31万
-
财政年份:2019
-
负责人:DANIEL D KARP
-
依托单位:
Center for Clinical and Translational Sciences (CCTS)
-
批准号:10655023
-
项目类别:
-
资助金额:$7.15万
-
财政年份:2019
-
负责人:DANIEL D KARP
-
依托单位:
Convalescent Plasma to Limit Coronavirus Associated Complications
-
批准号:10224557
-
项目类别:
-
资助金额:$984.32万
-
财政年份:2019
-
负责人:DANIEL D KARP
-
依托单位:
Center for Clinical and Translational Sciences (CCTS)
-
批准号:9983233
-
项目类别:
-
资助金额:$562.2万
-
财政年份:2019
-
负责人:DANIEL D KARP
-
依托单位:
Center for Clinical and Translational Sciences (CCTS)
-
批准号:10215640
-
项目类别:
-
资助金额:$575.06万
-
财政年份:2019
-
负责人:DANIEL D KARP
-
依托单位:
Center for Clinical and Translational Sciences (CCTS)
-
批准号:10441621
-
项目类别:
-
资助金额:$562.56万
-
财政年份:2019
-
负责人:DANIEL D KARP
-
依托单位:
Clinical and Translational
-
批准号:7695952
-
项目类别:
-
资助金额:$21.42万
-
财政年份:2008
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:2821778
-
项目类别:
-
资助金额:$14.65万
-
财政年份:1999
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:6173835
-
项目类别:
-
资助金额:$14.98万
-
财政年份:1999
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:6377050
-
项目类别:
-
资助金额:$13.84万
-
财政年份:1999
-
负责人:DANIEL D KARP
-
依托单位:
PRIMARY BREAST CANCER THERAPY GROUP-NSABP
-
批准号:3558508
-
项目类别:
-
资助金额:$6.24万
-
财政年份:1987
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:2084567
-
项目类别:
-
资助金额:$33.44万
-
财政年份:1982
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:3555878
-
项目类别:
-
资助金额:$29.27万
-
财政年份:1982
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:3555876
-
项目类别:
-
资助金额:$25.25万
-
财政年份:1982
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:2084568
-
项目类别:
-
资助金额:$35.81万
-
财政年份:1982
-
负责人:DANIEL D KARP
-
依托单位:
ONCOLOGY
-
批准号:3555871
-
项目类别:
-
资助金额:$4.53万
-
财政年份:1982
-
负责人:DANIEL D KARP
-
依托单位:
EASTERN COOPERATIVE ONCOLOGY GROUP
-
批准号:3555877
-
项目类别:
-
资助金额:$31.32万
-
财政年份:1982
-
负责人:DANIEL D KARP
-
依托单位:
海外基金